FDA To Phase Out Animal Testing In The Development Of Monoclonal Antibodies, Other Drugs

The U.S. Food and Drug Administration has announced a plan to replace animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods. The plan is in line with the agency's efforts to modernize regulatory science as technology advances, and follows the demand by Congress and the scientific community over the years for more human...

from RTT - Top Story https://ift.tt/XcZu42E
via IFTTT